The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neoadjuvant tislelizumab combined with lenvatinib plus transcatheter arterial chemoembolization in resectable hepatocellular carcinoma with high-risk of recurrence: A prospective, single-arm, phase II trial.
 
Zhiyu Chen
No Relationships to Disclose
 
Leida Zhang
No Relationships to Disclose
 
Hui Zhang
No Relationships to Disclose
 
Yi Gong
No Relationships to Disclose
 
Kai Feng
No Relationships to Disclose
 
Kuansheng Ma
No Relationships to Disclose
 
Huaqiang Bi
No Relationships to Disclose
 
Feng Xia
No Relationships to Disclose
 
Haisu Dai
No Relationships to Disclose